IMVT NASDAQ
Immunovant, Inc.
1W: +1.0%
1M: -14.9%
3M: -12.9%
YTD: +29.8%
1Y: +105.8%
3Y: -14.9%
5Y: +288.7%
$33.62
-0.03 (-0.09%)
Weekly Expected Move ±4.8%
$30
$32
$34
$35
$37
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
3 relationships3
As Filer
counterparties named
0
As Counterparty
mentioned by others
2
Rel. Types
2021-08-02
Earliest Filing
2025-01-13
Latest Filing
investor: 2
supplier: 1
Counterparties (Filed by IMVT)
3 relationshipsCompanies named in IMVT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. | ROIV | investor | Institutional accredited investor participating in the private placement of common stock. | 2025-01-13 | View |
| Samsung Biologics Co., Ltd. | — | supplier | Manufacturing and supply agreement for batoclimab drug substance | 2021-11-23 | View |
| Roivant Sciences Ltd. | ROIV | investor | Roivant agreed to purchase 17,021,276 shares of Immunovant common stock for $200 million. | 2021-08-02 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-09-03 | Shareholder Vote | View | |
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-05-20 | Earnings Release; Exhibits | View | |
| 2026-02-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-12-12 | Other Events; Financial Statements and Exhibits | View | |
| 2025-12-11 | Other Events | View | |
| 2025-11-21 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-11-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-08-28 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-08-11 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-07-29 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-05-29 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-21 | Departure/Election of Directors; Appointment of Officers; Regulation FD Disclosure; Other Events; Fi | View | |
| 2025-03-19 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2025-02-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-01-24 | Other Events; Financial Statements and Exhibits | View | |
| 2025-01-14 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-01-13 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Regulation FD Dis | Agreement | View |
| 2024-11-07 | Results of Operations and Financial Condition; Other Events; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR